Skip to main content
SpringerLink
Log in

Infections in the Cardiac Intensive Care Unit

  • Chapter
  • First Online:
Critical Care of Children with Heart Disease

  • 1485 Accesses

Abstract

Children in the cardiac intensive care unit (CICU) are at a high risk of infections. This may be due to underlying immunodeficiency and iatrogenic alterations in the immune system or due to invasive procedures. Some patients are admitted to the CICU primarily due to an infection, while others develop secondary infections once they are in the CICU setting. This chapter reviews the types of infections that can occur in the pediatric CICU to give an understanding of predisposing factors, primary and secondary infections.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Parshuram CS, Doyle J, Lau W, et al. Transfusion-associated graft versus host disease. Pediatr Crit Care Med. 2002;3(1):57–62.

    Article  PubMed  Google Scholar 

  2. Eckerle I, Rosenberger KD, Zwahlen M, Junghanss T. Serologic vaccination response after solid organ transplantation: a systematic review. PLoS One. 2013;8(2):e56974.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Varan B, Tokel K, Yilmaz G. Malnutrition and growth failure in cyanotic and acyanotic congenital heart disease with and without pulmonary hypertension. Arch Dis Child. 1999;81:49–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Levy I, Ovadia B, Erez E, et al. Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors. J Hosp Infect. 2003;53:111–116.

    Article  CAS  PubMed  Google Scholar 

  5. O’Neill JM, Schutze GE, Heulitt MJ, et al. Nosocomial infections during extracorporeal membrane oxygenation. Intensive Care Med. 2001;27:1247–1253.

    Article  PubMed  Google Scholar 

  6. Adachi I, Burki S, Zafar F, Morales DLS. Pediatric ventricular assist devices. J Thorac Dis. 2015;7(12):2194.

    PubMed  PubMed Central  Google Scholar 

  7. Cabrera AG, Khan MS, Morales DLS, et al. Infectious complications and outcomes in children supported with left ventricular assist devices. J Heart Lung Transplant. 2013;32(5):518–524.

    Article  PubMed  Google Scholar 

  8. Lindenfeld J. Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. Circulation. 2004;110(24):3734–3740.

    Article  PubMed  Google Scholar 

  9. Haddad F, Deuse T, Pham M, et al. Changing trends in infectious disease in heart transplantation. J Heart Lung Transplant. 2010;29(3):306–315.

    Article  PubMed  Google Scholar 

  10. Anderson DJ, Podgorny K, Berríos-Torres SI, et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(6):605–627.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Murray MT, Krishnamurthy G, Corda R, et al. Surgical site infections and bloodstream infections in infants after cardiac surgery. J Thorac Cardiovasc Surg. 2014;148(1):259–265.

    Article  PubMed  Google Scholar 

  12. Nelson-McMillan K, Hornik CP, He X, et al. Delayed sternal closure in infant heart surgery-the importance of where and when: an analysis of the STS congenital heart surgery database. Ann Thorac Surg. 2016;102(5):1565–1572.

    Article  PubMed  Google Scholar 

  13. Tortoriello TA, Friedman JD, McKenzie ED, et al. Mediastinitis after pediatric cardiac surgery: a 15-year experience at a single institution. Ann Thorac Surg. 2003;76:1655–1660.

    Article  PubMed  Google Scholar 

  14. Huddleston CB. Mediastinal wound infections following pediatric cardiac surgery. Semin Thorac Cardiovasc Surg 2004;16:108–112.

    Article  PubMed  Google Scholar 

  15. Costello JM, Graham DA, Morrow DF, et al. Risk factors for surgical site infection after cardiac surgery in children. Ann Thorac Surg. 2010;89(6):1833–1842.

    Article  PubMed  Google Scholar 

  16. Long CB, Shah SS, Lautenbach E, et al. Postoperative mediastinitis in children: epidemiology, microbiology and risk factors for Gram-negative pathogens. Pediatr Infect Dis J. 2005;24:315–319.

    Article  PubMed  Google Scholar 

  17. Álvarez P, Fuentes C, García N, Modesto V. Evaluation of the duration of the antibiotic prophylaxis in paediatric postoperative heart surgery patients. Pediatr Cardiol. 2012;33(5):735–738.

    Article  PubMed  Google Scholar 

  18. Alphonso N, Anagnostopoulos PV, Scarpace S, et al. Perioperative antibiotic prophylaxis in paediatric cardiac surgery. Cardiol Young. 2007;17(1):12–25.

    Article  PubMed  Google Scholar 

  19. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;49(1):1–45.

    Article  CAS  PubMed  Google Scholar 

  20. Prasad PA, Dominguez TE, Zaoutis TE, et al. Risk factors for catheter-associated bloodstream infections in a pediatric cardiac intensive care unit. Pediatr Infect Dis J. 2010;29(9):812–815.

    Article  PubMed  Google Scholar 

  21. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162–e193.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Garland JS, Alex CP, Hendrikson KJ, et al. A vancomycinheparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics. 2005;116:e198–e205.

    Article  PubMed  Google Scholar 

  23. Kabbani MS, Ismail SR, Fatima A, et al. Urinary tract infection in children after cardiac surgery: incidence, causes, risk factors and outcomes in a single-center study. J Infect Public Health. 2016;9(5):600–610.

    Article  PubMed  Google Scholar 

  24. Sahu MK, Siddharth B, Choudhury A, et al. Incidence, microbiological profile of nosocomial infections, and their antibiotic resistance patterns in a high volume cardiac surgical intensive care unit. Ann Card Anaesth. 2016;19(2):281–287.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Tan L, Sun X, Zhu X, et al. Epidemiology of nosocomial pneumonia in infants after cardiac surgery. Chest. 2004;125:410–417.

    Article  PubMed  Google Scholar 

  26. Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63(5):e61-e111.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Stramer SL. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med. 2007;131(5):702–707.

    PubMed  Google Scholar 

  28. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid–amplification testing. N Engl J Med. 2004;351(8):760–768.

    Article  CAS  PubMed  Google Scholar 

  29. Qu L, Xu S, Rowe D, Triulzi D. Efficacy of Epstein-Barr virus removal by leukoreduction of red blood cells. Transfusion. 2005;45:591–595.

    Article  PubMed  Google Scholar 

  30. Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003;42:466–472.

    Article  PubMed  Google Scholar 

  31. Martin AB, Webber S, Fricker FJ, et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation. 1994;90:330–339.

    Article  CAS  PubMed  Google Scholar 

  32. Zack F, Klingel K, Kandolf R, et al. Sudden cardiac death in a 5-year-old girl associated with parvovirus B19 infection. Forensic Sci Int. 2005;155:13–17.

    Article  CAS  PubMed  Google Scholar 

  33. Tabbutt S, Leonard M, Godinez RI, et al. Severe influenza B myocarditis and myositis. Pediatr Crit Care Med. 2004;5:403–406.

    Article  PubMed  Google Scholar 

  34. Kyto V, Vuorinen T, Saukko P, et al. Cytomegalovirus infection of the heart is common in patients with fatal myocarditis. Clin Infect Dis. 2005;40:683–638.

    Article  PubMed  Google Scholar 

  35. Merchant Q, Haque A, Hasan BS. Management of acute myocarditis in children. J Pak Med Assoc. 2013;63(6):803–811.

    PubMed  Google Scholar 

  36. Noren GR, Stanley NA, Bandt CM, et al. Occurrence of myocarditis in sudden death in children. J Forensic Sci. 1977;22:188–196.

    Article  CAS  PubMed  Google Scholar 

  37. Levi D, Alejos J. An approach to the treatment of pediatric myocarditis. Paediatr Drugs. 2002;4:637–647.

    Article  PubMed  Google Scholar 

  38. Mills KI, Vincent JA, Zuckerman WA, et al. Is endomyocardial biopsy a safe and useful procedure in children with suspected cardiomyopathy? Pediatr Cardiol. 2016;37(7):1200–1210.

    Article  PubMed  Google Scholar 

  39. Goitein O, Matetzky S, Beinart R, et al. Acute myocarditis: noninvasive evaluation with cardiac MRI and transthoracic echocardiography. AJR Am J Roentgenol. 2009;192(1):254–258.

    Article  PubMed  Google Scholar 

  40. Prasad AN, Chaudhary S. Intravenous immunoglobulin in children with acute myocarditis and/or early dilated cardiomyopathy. Indian Pediatr. 2014;51(7):583–584.

    Article  PubMed  Google Scholar 

  41. Robinson J, Hartling L, Vandermeer B, Klassen TP. Intravenous immunoglobulin for presumed viral myocarditis in children and adults. In: The Cochrane Collaboration, ed. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2015.

    Google Scholar 

  42. McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation. 2001;103:2254–2259.

    Article  CAS  PubMed  Google Scholar 

  43. Bhatt GC, Sankar J, Kushwaha KP. Use of intravenous immunoglobulin compared with standard therapy is associated with improved clinical outcomes in children with acute encephalitis syndrome complicated by myocarditis. Pediatr Cardiol. 2012;33(8):1370–1376.

    Article  PubMed  Google Scholar 

  44. Chen HS, Wang W, Wu SN, Liu JP. Corticosteroids for viral myocarditis. Cochrane Database Syst Rev. 2013;(10):CD004471.

    Google Scholar 

  45. Abzug MJ, Michaels MG, Wald E, et al. A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis. J Pediatric Infect Dis Soc. 2016;5(1):53–62.

    Article  PubMed  Google Scholar 

  46. Khongphattanayouthin A, Wong PC, Samara Y, et al. Impact of respiratory syncytial virus infection on surgery for congenital heart disease: postoperative course and outcome. Crit Care Med. 1999;27:1974–1981.

    Article  Google Scholar 

  47. Altman CA, Englund JA, Demmler G, et al. Respiratory syncytial virus in patients with congenital heart disease: a contemporary look at epidemiology and success of preoperative screening. Pediatr Cardiol. 2000;21:433–438.

    Article  CAS  PubMed  Google Scholar 

  48. Apalsch AM, Green M, Ledesma-Medina J, et al. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis. 1995;20:394–399.

    Article  CAS  PubMed  Google Scholar 

  49. Committee on Infectious Diseases and Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus Infection. Pediatrics. 2014;134(2):e620–e638.

    Article  Google Scholar 

  50. Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev. 2007;(1):CD000181.

    Google Scholar 

  51. Turner TL, Kopp BT, Paul G, Landgrave LC, Hayes D, Thompson R. Respiratory syncytial virus: current and emerging treatment options. Clinicoecon Outcomes Res. 2014;6:217–225.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Kotton CN, Kumar D, Caliendo AM, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96(4):333–360.

    Article  CAS  PubMed  Google Scholar 

  53. Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013;13(suppl 3):41–54; quiz 54.

    Article  CAS  PubMed  Google Scholar 

  54. Green M. Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation. Am J Transplant. 2001;1:103–108.

    CAS  PubMed  Google Scholar 

  55. Elstrom RL, Andreadis C, Aqui NA, et al. Treatment of PTLD with rituximab or chemotherapy. Am J Transplant. 2006;6(3):569–576.

    Article  CAS  PubMed  Google Scholar 

  56. Avery RK, Longworth DL. Viral pulmonary infections in thoracic and cardiovascular surgery. Semin Thorac Cardiovasc Surg. 1995;7:88–94.

    CAS  PubMed  Google Scholar 

  57. Weigl JA, Puppe W, Schmitt HJ. The incidence of influenza-associated hospitalization in children in Germany. Epidemiol Infect. 2002;129:525–533.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Admon D, Engelhard D, Strauss N, et al. Antibody response to influenza immunization in patients after heart transplantation. Vaccine. 1997;15:1518–1522.

    Article  CAS  PubMed  Google Scholar 

  59. Jaworski R, Haponiuk I, Irga-Jaworska N, et al. Fungal infections in children in the early postoperative period after cardiac surgery for congenital heart disease: a single-centre experience. Interact Cardiovasc Thorac Surg. 2016;23(3):431–437.

    Article  PubMed  Google Scholar 

  60. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220(6):751–758.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Zaoutis TE, Webber S, Naftel DC, et al. Invasive fungal infections in pediatric heart transplant recipients: incidence, risk factors, and outcomes. Pediatr Transplant. 2011;15(5):465–469.

    Article  PubMed  Google Scholar 

  62. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1–e50.

    Article  PubMed  Google Scholar 

  63. McGhee W, Michaels MG, Martin JM, Mazariegos GV, Green M. Antifungal lock therapy with liposomal amphotericin B: a prospective trial. J Pediatric Infect Dis Soc. 2016;5(1):80–84.

    Article  PubMed  Google Scholar 

  64. Keough WL, Michaels MG. Infectious complications in pediatric solid organ transplantation. Pediatr Clin North Am. 2003;50:1451–1469.

    Article  PubMed  Google Scholar 

  65. Hermanns B, Brunn A, Schwartz ER, et al. Fulminant toxoplasmosis in a heart transplant recipient. Pathol Res Pract. 2001;197:211–215.

    Article  CAS  PubMed  Google Scholar 

  66. Michaels MG, Wald ER, del Nido PJ, Armitage J. Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis. 1992;14:847–851.

    Article  CAS  PubMed  Google Scholar 

  67. Gallino A, Maggiorini M, Kiowski W, et al. Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis. 1996;15:389–393.

    Article  CAS  PubMed  Google Scholar 

  68. Baden LR, Katz JT, Franck L, et al. Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole. Transplantation. 2003;75:339–343.

    Article  CAS  PubMed  Google Scholar 

  69. Kotton CN. Update on infectious diseases in pediatric solid organ transplantation: Curr Opin Organ Transplant. 2008;13(5):500–505.

    Article  PubMed  Google Scholar 

  70. Archibald LK, Manning ML, Bell LM, et al. Patient density, nurse-to-patient ratio and nosocomial infection risk in a pediatric cardiac intensive care unit. Pediatr Infect Dis J. 1997;16:1045–1048.

    Article  CAS  PubMed  Google Scholar 

  71. Romero JR. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage. Pediatr Infect Dis J. 2003;22:S46–S54.

    PubMed  Google Scholar 

  72. Cabalka AK. Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease. Pediatr Infect Dis J. 2004;23:S41–S45.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Infectious Diseases, Arkansas Children’s Hospital, Little Rock, AR, USA

    Timothy Onarecker

  2. Pediatric Infectious Diseases, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA

    Marian G. Michaels

Authors
  1. Timothy Onarecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marian G. Michaels
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marian G. Michaels .

Editor information

Editors and Affiliations

  1. Chief, Division of Cardiac Critical Care Medicine Executive Director, Telemedicine Co-director, Children’s National Heart Institute, Professor of Pediatrics, George Washington University School of Medicine, Children’s National Health System, Washington, DC, USA

    Ricardo A. Munoz

  2. Department of Pediatric Cardiothoracic Surgery, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA

    Victor O. Morell

  3. Associate Medical Director, CHCO Heart Institute Head, Pediatric Cardiac Critical Care Program & Inpatient Services Director, Cardiac Intensive Care Unit Children’s Hospital Colorado, Tenured Professor of Pediatrics, Pediatric Cardiology and Intensive Care University of Colorado Denver, School of Medicine, Aurora, CO, USA

    Eduardo M. da Cruz

  4. Department of Pharmacy, Pediatric Critical Care, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA

    Carol G. Vetterly

  5. Department of Pediatric Cardiothoracic Surgery, UPMC – Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA

    Jose Pedro da Silva

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Onarecker, T., Michaels, M.G. (2020). Infections in the Cardiac Intensive Care Unit. In: Munoz, R., Morell, V., da Cruz, E., Vetterly, C., da Silva, J. (eds) Critical Care of Children with Heart Disease . Springer, Cham. https://doi.org/10.1007/978-3-030-21870-6_60

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21870-6_60

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21869-0

  • Online ISBN: 978-3-030-21870-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation